System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+909 today

System

Live2m

Terminal Asset View

stockNASDAQ

BEAM

$25.16-1.68%

Beam Therapeutics Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

24Neutral

Live Analysis Active

Company Mission

Beam Therapeutics creates genetic medicines that use precise DNA editing to treat serious diseases. Their technology allows doctors to target specific genetic mutations that cause illnesses. The company makes money through research partnerships with pharmaceutical companies and hopes to eventually sell approved treatments to patients and healthcare providers.

BEA

Industry Context

The biotechnology industry focuses on developing treatments using biological systems. Gene editing companies work on technologies that can modify DNA to treat genetic diseases. This field has seen significant investment as new treatments show promise in clinical trials.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

61Matrix

Market Momentum

40.8— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.9x— Normal Volume

Today's Change

-1.68%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Live Sync

Social Intelligence Pulse.

Our engine is currently indexing BEAM across global social channels to detect early sentiment shifts and technical alignment.

XActive

RedditActive

WebActive

Social Growth+3.0% vs 7D

Signal CoverageStandard Coverage

Signal Catalysts

Intelligence Narrative Connected

Updated 11:19 PM UTC

As-of 03-14-2026 23:04 UTC

Develops gene-editing medicines that fix DNA errors and makes money by licensing its technology to drug companies and selling treatments.

Monthly chart shows base formation near recent lows, suggesting a strong foundation for potential moves as buyers establish support.

Biotech sector showing renewed interest in gene editing platforms, which could benefit companies with advanced technology like this one.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...